Entera Bio Ltd. Files 8-K on Shareholder Vote Matters
Ticker: ENTX · Form: 8-K · Filed: Jul 18, 2025 · CIK: 1638097
| Field | Detail |
|---|---|
| Company | Entera Bio LTD. (ENTX) |
| Form Type | 8-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, warrants, corporate-action
TL;DR
Entera Bio (ENTX) filed an 8-K for a shareholder vote on July 16th. Warrants at $5.85.
AI Summary
Entera Bio Ltd. filed an 8-K on July 18, 2025, reporting a submission of matters to a vote of security holders on July 16, 2025. The company is involved in biological products and has warrants exercisable for Ordinary Shares at $5.85 each.
Why It Matters
This filing indicates a significant corporate event requiring shareholder approval, which could impact the company's future direction and share structure.
Risk Assessment
Risk Level: medium — Filings related to shareholder votes can introduce uncertainty regarding corporate actions and potential dilution.
Key Numbers
- $5.85 — Warrant Exercise Price (Price at which warrants can be exercised for Ordinary Shares.)
Key Players & Entities
- Entera Bio Ltd. (company) — Registrant
- July 16, 2025 (date) — Earliest event reported
- July 18, 2025 (date) — Filing date
- $5.85 (dollar_amount) — Warrant exercise price
FAQ
What specific matters are being submitted for a vote of Entera Bio Ltd.'s security holders?
The filing states 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 16, 2025.
What is the exercise price for Entera Bio Ltd.'s warrants?
The exercise price for the warrants is $5.85 per Ordinary Share.
What is the ticker symbol for Entera Bio Ltd.'s warrants?
The ticker symbol for the warrants is ENTXW.
In which jurisdiction is Entera Bio Ltd. incorporated?
Entera Bio Ltd. is incorporated in Israel.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding Entera Bio Ltd. (ENTX).